A long-awaited amendment to the Czech Medicines Act came into force on 1 January 2024. What practical impact will it have?
SK&S Advises Straumann Holding on Acquisition of Schmidt Dental
Soltysinski Kawecki & Szlezak has advised Straumann Holding on its acquisition of Schmidt Dental from Oliver Schmidt. Burzak Okon and Partners reportedly advised Schmidt on the sale.
Shortage of Critical Medicines: is a European Solution Available?
There has been much discussion about protracted shortages of critical medicines in the Czech Republic over the last couple of months. Many national measures have been adopted. At the European Union level,the Voluntary Solidarity Mechanism for medicines has been put in place.
PRK Partners Advises Affimed on Divestment of AbCheck
PRK Partners has advised Affimed on its successful divestment of AbCheck to Flagship Pioneering company Ampersand Biomedicines.
Musat & Asociatii Mints Three New Partners and Appoints New Deputy Managing Partner
Dan Minoiu has become a new Deputy Managing Partner at Musat & Asociatii, while Ana Maria Abrudan, Mateea Codreanu, and Stefan Diaconescu have all been promoted to Partner positions.
Wojciech Kulczyk and Krzysztof Sikorski Make Partner at WKB Lawyers
Attorneys-at-Law Wojciech Kulczyk and Krzysztof Sikorski have been elevated to Partner positions with WKB Lawyers at the start of 2024.
Tuca Zbarcea & Asociatii Advises Amethyst Radiotherapy Group on Sale of Buildings to BT Property Alternative REIF
Tuca Zbarcea & Asociatii has advised the Amethyst Radiotherapy Group on the sale and lease-back of three buildings to the BT Property Alternative Real Estate Investment Fund.